Steris vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 77)
Steris logo

Steris

LeaderHealthcare Tech

Sterilization & Infection Prevention

Steris plc (STE) reported ~$5.5B revenue in FY2024. Global leader in sterilization, decontamination, and infection prevention products and services for healthcare and life sciences. HQ: Dublin / Mentor, OH.

AI VisibilityBeta
Overall Score
B77
Category Rank
#55 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
82
Perplexity
76
Gemini
79

About

STERIS plc is the global leader in sterilization, reprocessing, and decontamination services and products for the healthcare and life sciences industries. The company provides the steam sterilizers, hydrogen peroxide sterilizers, endoscope reprocessors, and facility cleaning products that make surgical equipment safe to reuse — a critical but often invisible part of healthcare operations. STERIS also offers sterilization contract services for medical device manufacturers, processing implants, surgical instruments, and single-use devices at over 60 facilities worldwide.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

77
Overall Score
90
#55
Category Rank
#2
81
AI Consensus
83
stable
Trend
stable
82
ChatGPT
92
76
Perplexity
93
79
Gemini
89
78
Claude
96
74
Grok
95

Key Details

Category
Sterilization & Infection Prevention
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Steris
Sterilization & Infection Prevention

Integrations

Only Steris
Only Moderna
Steris is classified as company. Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.